Regorafenib
- Level
- Commodity
- Parent
- 51112000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51112028Regorafenib is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase.
Same parent
Under 51112000 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.